Mereo BioPharma Group PLC (MREO)
3.72
+0.04
(+1.09%)
USD |
NASDAQ |
Nov 22, 16:00
3.725
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.001M |
| March 31, 2024 | -0.70M |
| December 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.419M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.70M
Minimum
Mar 2024
0.001M
Maximum
Jun 2024
-0.1597M
Average
--
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | -0.0071M |
| NuCana PLC | -0.0053M |
| Biodexa Pharmaceuticals PLC | -- |
| Adaptimmune Therapeutics PLC | -66.02M |
| DBV Technologies SA | -0.109M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.519M |
| Cash from Financing (Quarterly) | -0.594M |
| Free Cash Flow | -30.90M |
| Free Cash Flow Per Share (Quarterly) | -0.0488 |
| Free Cash Flow Yield | -5.76% |